首页> 外文期刊>BJOG: an international journal of obstetrics and gynaecology >Clinical and economic impact of school‐based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis
【24h】

Clinical and economic impact of school‐based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis

机译:校本非纳瓦洛人乳头瘤病毒疫苗对新加坡妇女的临床和经济影响:传导动态数学模型分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To examine the epidemiological and economic impact of a nine‐valent (nonavalent) human papillomavirus ( HPV ) 6/11/16/18/31/33/45/52/58 vaccine programme for young teenagers in Singapore. Design Mathematical modelling. Setting Pharmaco‐economic simulation projection. Population Singapore demography. Methods Clinical, epidemiological and financial data from Singapore were used in a validated HPV transmission dynamic mathematical model to analyse the impact of nonavalent HPV vaccination over quadrivalent and bivalent vaccines in a school‐based 2‐dose vaccination for 11‐ to 12‐year‐old girls in the country. The model assumed routine cytology screening in the current rate (50%) and vaccine coverage rate of 80%. Main outcome measures Changes over a 100‐year time period in the incidence and mortality rates of cervical cancer, case load of genital warts, and incremental cost–effectiveness ratio ( ICER ). Results Compared with bivalent and quadrivalent HPV vaccination programmes, nonavalent HPV universal vaccination resulted in an additional reduction of HPV 31/33/45/52/58 related CIN 1 of 40.5%, CIN 2/3 of 35.4%, cervical cancer of 23.5%, and cervical cancer mortality of 20.2%. Compared with bivalent HPV vaccination, there was an additional reduction in HPV ‐6/11 related CIN 1 of 75.7%, and genital warts of 78.9% in women and 73.4% in men. Over the 100?years, after applying a discount of 3%, disease management cost will be reduced by 32.5% (versus bivalent) and 7.5% (versus quadrivalent). The incremental cost‐effectiveness ratio ( ICER ) per quality‐adjusted life‐year gained was SGD 929 compared with bivalent vaccination and SGD 9864 compared with quadrivalent vaccination. Conclusion Universal two‐dose nonavalent HPV vaccination for 11‐ to 12‐year‐old adolescent women is very cost‐effective in Singapore. Tweetable abstract Nonavalent HPV vaccination of 11‐ to 12‐year‐old girls is cost‐effective in Singapore.
机译:目的探讨新加坡青少年青少年疫苗疫苗病毒(HPV)的流行病学和经济影响。设计数学建模。设定药学经济仿真投影。人口新加坡人口统计。方法在验证的HPV传播动态数学模型中使用新加坡的临床,流行病学和金融数据,分析了在基于学校的2剂疫苗中的四价和二价疫苗上的非AVALENT HPV疫苗接种的影响11-12岁女孩在这个国家。该模型假定当前速率(50%)和疫苗覆盖率为80%的常规细胞学筛查。主要结果措施在宫颈癌发生率和死亡率的发生率和死亡率,生殖器疣的案例负荷和增量成本效益率(ICER)中发生变化。结果与二价HPV疫苗接种方案相比,非寄生HPV通用疫苗接种导致HPV 31/33/45/52/58相关Cin1的额外减少40.5%,CIN 2/3的35.4%,宫颈癌为23.5% ,宫颈癌死亡率为20.2%。与二价HPV疫苗接种相比,HPV -6 / 11相关CIN1的额外减少75.7%,妇女的生殖器疣为78.9%和73.4%。超过100岁?多年来,施用3%的折扣后,疾病管理成本将减少32.5%(比率,比率)和7.5%(与四轮相比)。与二价疫苗接种相比,每个质量调整的寿命的增量成本效率(ICER)是SGD 929,与二价疫苗接种相比,SGD 9864相比。结论11至12岁的青少年女性的通用双剂量非游性HPV疫苗接种在新加坡非常成本效益。 11至12岁女孩11至12岁女孩的Temavalent HPV疫苗接种在新加坡具有成本效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号